| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |